October 9th 2007 | Uncategorized | 0 Comments
We’re not sure how to react to the findings from this scientific experiment:
Psoriasis patients learn to cope when others show disgust in response to their skin lesions by automatically shutting off a specific part of their brains, UK researchers report.
“In psoriasis patients, the brain appears to become ‘accustomed’ to facial expressions of disgust,” said principal
READ THE FULL POST
October 3rd 2007 | Uncategorized | 0 Comments
An experimental psoriasis treatment in late-stage trials showed strong results in clearing psoriasis and appeared safe for patients, according to study results reported at a world dermatology conference today. The biologic medicine, known as ustekinumab or CNTO 1275, was developed by Centocor, the company that currently markets Remicade for psoriasis and psoriatic arthritis.
READ THE FULL POST
